3
Announcements
Trials
Browse
Landscape
Status
Recruiting
6
Completed
6
Unknown
4
Withdrawn
1
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
6
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
144
Neoplasms
130
Prostatic Neoplasms
81
Carcinoma, Non-Small-Cell Lung
79
Lung Neoplasms
65
Colorectal Neoplasms
46
Carcinoma, Hepatocellular
37
Stomach Neoplasms
33
Multiple Myeloma
28
Brain Neoplasms
28
Uterine Cervical Neoplasms
27
Melanoma
26
Pancreatic Neoplasms
25
Rectal Neoplasms
24
Ovarian Neoplasms
24
Head and Neck Neoplasms
24
Colonic Neoplasms
23
Urinary Bladder Neoplasms
22
Hematologic Neoplasms
22
Neoplasm Metastasis
21
Carcinoma, Renal Cell
20
Leukemia, Myeloid, Acute
19
Esophageal Neoplasms
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
17
Endometrial Neoplasms
17
Recurrence
15
Cardiovascular Diseases
15
Thyroid Neoplasms
14
Lymphoma
14
Liver Neoplasms
14
Interventions
High-Throughput Nucleotide Sequencing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Observational
×
Hereditary Breast and Ovarian Cancer Syndrome
×
Clear all
NCT04261972
2026-01-14
CHARM1
University Health Network, Toronto
Active not recruiting
1,416 enrolled